4.4 Article

EUS-guided Gastrojejunostomy Versus Laparoscopic Gastrojejunostomy An International Collaborative Study

Journal

JOURNAL OF CLINICAL GASTROENTEROLOGY
Volume 51, Issue 10, Pages 896-899

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MCG.0000000000000887

Keywords

gastrojejunostomy; gastric outlet obstruction; EUS; EUS-GJ; GOO; LAMS

Funding

  1. Boston Scientific
  2. Fujinon
  3. EMcison
  4. Xlumena Inc.
  5. W.L. Gore
  6. MaunaKea
  7. Apollo Endosurgery
  8. Cook Endoscopy
  9. ASPIRE Bariatrics
  10. GI Dynamics
  11. NinePoint Medical
  12. Merit Medical
  13. Olympus
  14. MI Tech

Ask authors/readers for more resources

Introduction: Endoscopic ultrasound-guided gastrojejunostomy (EUS-GJ) with placement of a lumen-apposing metal stent is a minimally invasive and efficacious procedure for gastric outlet obstruction (GOO) patients not amenable to surgery. Laparoscopic gastrojejunostomy (Lap-GJ) has traditionally been the standard of care. No direct comparison between EUS-GJ and Lap-GJ has been described. Our aim was to compare the clinical outcomes, success rate, and adverse events (AE) of EUS-GJ with Lap-GJ. Methods: Patients with GOO from 4 academic centers in 3 countries were included. Technical success was defined as successful creation of a gastrojejunostomy. Clinical success was defined as the ability to tolerate a diet postprocedure. Results: Data were collected on 54 patients. A total of 25 patients underwent EUS-GJ (male n=11, mean age 63.9 y) and 29 patients underwent Lap-GJ (male n=22, mean age 75.8 y). Technical success was achieved in 29 (100%) Lap-GJ group patients and 23 (88%) in the EUS-GJ group (P=0.11). AEs occurred in 41% (n=12) of patients in the Lap-GJ group and 12% (n=3) in the EUS-GJ group (P=0.0386). According to the Clavien-Dindo Classification, the Lap-GJ group AEs were grade I (n=4), grade II (n=5), grade III (n=2), and grade V (n=1); the EUS-GJ AEs were grade II (n=2) and grade V (n=1). Conclusions: Although the EUS-GJ group contained more complex patients, efficacy was similar between the groups. AEs were significantly lower in the EUS-GJ group. EUS-GJ is a safe and efficacious, minimally invasive option for patients with GOO.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available